Andrew Huberman· PhD
So we think actually the subtyping is a big deal because again, it determines your lifestyle choices you might make to better control your glucose and of course drug responses as well.
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
So we think actually the subtyping is a big deal because again, it determines your lifestyle choices you might make to better control your glucose and of course drug responses as well.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
So knowing your sub phenotype is a big deal. But then I respond to certain drug repinolide that actually promotes that release. So knowing your sub phenotype determines your drugs.
the implication by the way is any physician who approaches a patient with type 2 diabetes as a single entity is going to be providing suboptimal care yes
it's a you have to take a Precision medicine approach to type diabetes which Begins by trying to identify which phenotype your patient is before we C